We are live on ! Find out more
FBLG icon

FibroBiologics
FBLG

52 hedge funds and large institutions have $3.28M invested in FibroBiologics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.14% less ownership

Funds ownership: 0.78% → 0.64% (-0.14%)

9% less funds holding

Funds holding: 57 → 52 (-5)

12% less capital invested

Capital invested by funds: $3.75M → $3.28M (-$467K)

38% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 13

55% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 20

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
52
Holders Change
-5
Holders Change %
-8.77%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
8
Increased
9
Reduced
20
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LCM
Landscape Capital Management
New Jersey
+$210K
2
GS
GTS Securities
New York
+$185K
3
Renaissance Technologies
Renaissance Technologies
New York
+$35.8K
4
P
&Partners
Tennessee
+$18K
5
LM
Luminus Management
Texas
+$15.9K

Top Sellers

Rank Fund Capital Flow
1
YAG
Yorkville Advisors Global
New Jersey
-$200K
2
BlackRock
BlackRock
New York
-$186K
3
Goldman Sachs
Goldman Sachs
New York
-$72.5K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$66K
5
Jane Street
Jane Street
New York
-$59.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$674K – – –
LM
2
Luminus Management
Texas
$346K +$15.9K +1,331 New
YAG
3
Yorkville Advisors Global
New Jersey
$278K -$200K -16,716 -40%
Millennium Management
4
Millennium Management
New York
$244K -$20.6K -1,722 -7%
BlackRock
5
BlackRock
New York
$240K -$186K -15,556 -41%
LCM
6
Landscape Capital Management
New Jersey
$191K +$210K +17,500 New
GS
7
GTS Securities
New York
$169K +$185K +15,433 New
CFP
8
Cascade Financial Partners
California
$163K +$4.49K +375 +3%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$158K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$115K -$13.3K -1,111 -10%
Cerity Partners
11
Cerity Partners
New York
$68.8K -$1.3K -109 -2%
State Street
12
State Street
Massachusetts
$60.8K -$2.52K -210 -4%
OAS
13
Optivise Advisory Services
Tennessee
$60.1K – – –
RCM
14
Requisite Capital Management
Texas
$59.9K – – –
P
15
&Partners
Tennessee
$54.6K +$18K +1,500 +43%
AIFAIM
16
American Institute for Advanced Investment Management
Arizona
$48.2K – – –
UBS Group
17
UBS Group
Switzerland
$42.3K -$19.7K -1,642 -30%
Renaissance Technologies
18
Renaissance Technologies
New York
$32.7K +$35.8K +2,990 New
Bank of America
19
Bank of America
North Carolina
$26.3K +$251 +21 +0.9%
Northern Trust
20
Northern Trust
Illinois
$26K -$263 -22 -0.9%
SI
21
Saxon Interests
Texas
$24.3K +$12K +1,000 +94%
HF
22
HRT Financial
New York
$24K +$3.8K +317 +17%
RWB
23
RMR Wealth Builders
New Jersey
$21K – – –
CIA
24
Concurrent Investment Advisors
Florida
$19.3K – – –
Qube Research & Technologies (QRT)
25
Qube Research & Technologies (QRT)
United Kingdom
$16.4K -$2.48K -207 -12%
1
2 3

FBLG Hedge Fund Activity: Q3 2025 in Review

52 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in FibroBiologics (FBLG) for Q3 2025, worth a combined $3.28M — down 12% from $3.75M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of FBLG and 8 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 9 added.

The largest buyer was Landscape Capital Management, opening a new position worth an estimated $210K. The largest seller was Yorkville Advisors Global, cutting an estimated $200K.

  • 52 institutional investors held FibroBiologics (FBLG) as of Q3 2025, down from 57 in Q2 2025.
  • Funds reported $3.28M of FibroBiologics stock for Q3 2025, down 12% quarter-over-quarter.
  • 8 funds opened new FibroBiologics positions in Q3 2025 and 13 closed out, a net change of -5 holders.
  • The largest FibroBiologics buyer in Q3 2025 was Landscape Capital Management, an estimated $210K added.
  • The largest FibroBiologics seller in Q3 2025 was Yorkville Advisors Global, an estimated $200K sold.

Based on aggregated 13F filings for Q3 2025.